Swedish-Nature-26-1248x672

Biomarker Profiling

From multiplex ELISA to custom biomarker assay development, we help you generate actionable insights for precision medicine.

discussion-504x672

Biomarker Profiling

Biomarker Profiling

Biomarker profiling plays a critical role in understanding disease pathways, monitoring therapeutic response, and predicting safety risks. It enables personalized treatment strategies and supports regulatory submissions.

How we can help

Unlock critical insights into disease mechanisms and therapeutic response with our biomarker profiling solutions.  We provide flexible biomarker profiling solutions to accelerate your research and development.

From custom assay development to multiplex ELISA and complement biomarker analysis, our CRO services and iLite® functional bioassays deliver reliable, actionable data.

Through partnerships with Olink®, Simoa®, and Lablytica, we extend access to advanced technologies for comprehensive biomarker analysis

Our biomarker profiling solutions support you with:

  • Efficacy and Safety: Confirm therapeutic effect and identify adverse responses.
  • Patient Stratification: Enable targeted therapies for specific patient groups.
  • Regulatory Compliance: Provide mechanism-of-action data for approval.

Our Biomarker Profiling Solutions

  • COMPLEMENT ASSAYS

    WIESLAB® kits cover key complement components and split products for precise pathway attribution. The ELISA format simplifies implementation and is ideal for cross‑site studies and comparability assessments.

    Complement Assays

  • COMPLEMENT ASSAYS

    We quantify complement factors and inflammatory mediators to illuminate innate and adaptive responses. Kits and service panels are appropriate for safety profiling, MoA confirmation, and longitudinal response tracking.

    Complement Assays

  • CELL-BASED BIOASSAYS

    iLite assays translate pathway activation into quantitative luminescent signals that reflect mechanism of action. Assay‑ready cells reduce variability and are suitable for potency‑linked biomarker analysis and pharmacodynamic studies.

    Luciferase Reporter Assays

  • CELL-BASED BIOASSAYS

    We design and validate assays tailored to your disease biology and endpoints, covering protein, cell‑based, and functional markers. Delivered with documented performance characteristics, these assays support exploratory research and regulated decision points.

    Custom Assays

  • CRO SERVICES

    We support hypothesis generation through discovery panels and custom marker selection to identify predictive or prognostic signatures. Data packages include statistical summaries and transfer options for downstream validation.

    Biomarker Services

  • CRO SERVICES

    Our team develops, qualifies, and runs biomarker assays with rigorous QC to ensure consistent, audit‑ready datasets. Available across preclinical and clinical phases, with standardized reporting and sample logistics support.

    Bioanalytical Services

  • WIESLAB DIAGNOSTIC SERVICES

    With over 30 years of experience in autoimmune diagnostics, our ISO15189-accredited specialist laboratory can help you reach the correct diagnosis. We offer testing for a range of biomarkers.

    Wieslab Diagnostic Services

  • CRO SERVICES

    As an Olink® Certified Service Provider, we deliver advanced biomarker solutions using Olink’s unique Proximity Extension Assay (PEA) technology. Our platform supports sensitive, scalable multiplex protein analysis for both broad discovery and targeted profiling. Services include comprehensive discovery panels, targeted assays, and data packages with statistical interpretation, plus options for downstream validation.

    Bimarker Discovery Services

  • CRO & WIESLAB DIAGNOSTIC SERVICES

    We deliver advanced biomarker solutions using Single Molecule Array (Simoa) technology, enabling femtomolar sensitivity for exploratory detection across diverse biological matrices and surpassing traditional ELISA limits. Our services include assays in a wide range of therapeutic areas from oncology to infectious diseases, with options for custom Simoa-based assay development supported by over 30 years of assay expertise.

    Biomarker Discovery Services Wieslab Diagnostic Services

  • CRO SERVICES

    Through our partner, Lablytica, our clients gain access to GLP-certified LC-MS/MS solutions dedicated to biomarker quantification. Services cover method development, validation, and generation of high-quality data packages to support verification and longitudinal studies, delivered under strict regulatory compliance.

    Biomarker Discovery Services

Contact our team of experts

Write us a message and a product specialist will get in touch